Evidera
Keila Meginnis is a Senior Research Associate at Evidera, with prior experience as a Research Associate. Previous roles include Lecturer in One Health and Environmental Economics at the University of Glasgow and Research Fellow at the University of Stirling, where work focused on the economic aspects of marine plastic pollution under an ESRC grant. Keila has also served as a Post-Doctoral Research Assistant at the University of Glasgow, analyzing cultural and economic factors in disease transmission, and has held teaching and research positions at the University of Manchester and the University of Puget Sound. Keila holds a Ph.D. in Economics from The University of Manchester, a Master's Degree from The University of Edinburgh, and dual degrees in Economics and French from the University of Puget Sound.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.